Cargando…

Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana

BACKGROUND: Previous studies have reported that presence and severity of Buruli ulcer (BU) may reflect the underlying immunosuppression in HIV infected individuals by causing increased incidence of multiple, larger and ulcerated lesions. We report cases of BU-HIV coinfection and the accompanying pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoako, Yaw Ampem, Loglo, Aloysius Dzigbordi, Frimpong, Michael, Agbavor, Bernadette, Abass, Mohammed Kabiru, Amofa, George, Ofori, Elizabeth, Ampadu, Edwin, Asiedu, Kingsley, Stienstra, Ymkje, Wansbrough-Jones, Mark, van der Werf, Tjip, Phillips, Richard Odame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028811/
https://www.ncbi.nlm.nih.gov/pubmed/33832460
http://dx.doi.org/10.1186/s12879-021-06009-7
_version_ 1783676011406163968
author Amoako, Yaw Ampem
Loglo, Aloysius Dzigbordi
Frimpong, Michael
Agbavor, Bernadette
Abass, Mohammed Kabiru
Amofa, George
Ofori, Elizabeth
Ampadu, Edwin
Asiedu, Kingsley
Stienstra, Ymkje
Wansbrough-Jones, Mark
van der Werf, Tjip
Phillips, Richard Odame
author_facet Amoako, Yaw Ampem
Loglo, Aloysius Dzigbordi
Frimpong, Michael
Agbavor, Bernadette
Abass, Mohammed Kabiru
Amofa, George
Ofori, Elizabeth
Ampadu, Edwin
Asiedu, Kingsley
Stienstra, Ymkje
Wansbrough-Jones, Mark
van der Werf, Tjip
Phillips, Richard Odame
author_sort Amoako, Yaw Ampem
collection PubMed
description BACKGROUND: Previous studies have reported that presence and severity of Buruli ulcer (BU) may reflect the underlying immunosuppression in HIV infected individuals by causing increased incidence of multiple, larger and ulcerated lesions. We report cases of BU-HIV coinfection and the accompanying programmatic challenges encountered in central Ghana. METHODS: Patients with PCR confirmed BU in central Ghana who were HIV positive were identified and their BU01 forms were retrieved and reviewed in further detail. A combined 16S rRNA reverse transcriptase / IS2404 qPCR assay was used to assess the Mycobacterium ulcerans load. The characteristics of coinfected patients (BU(+)HIV(+)) were compared with a group of matched controls. RESULTS: The prevalence of HIV in this BU cohort was 2.4% (compared to national HIV prevalence of 1.7%). Eight of 9 BU(+)HIV(+) patients had a single lesion and ulcers were the most common lesion type. The lesions presented were predominantly category II (5/9) followed by category I lesions. The median (IQR) time to healing was 14 (8–28) weeks in the BU(+)HIV(+) compared to 28 (12–33) weeks in the control BU(+)HIV(−) group (p = 0.360). Only one BU(+)HIV(+) developed a paradoxical reaction at week 16 but the lesion healed completely at week 20. The median bacterial load (16SrRNA) of BU(+)HIV(+) patients was 750 copies /ml (95% CI 0–398,000) versus 500 copies/ml (95% CI 0–126,855,500) in BU(+)HIV(−) group. Similarly, the median count using the IS2404 assay was 500 copies/ml (95% CI 0–500) for BU(+)HIV(+) patients versus 500 copies/ml (95% CI 500–31,000) for BU(+)HIV(−) patients. BU(+)HIV(−) patients mounted a significantly higher interferon-γ response compared to the BU(+)HIV(+) co-infected patients with respective median (range) responses of [1687(81.11–4399) pg/ml] versus [137.5(4.436–1406) pg/ml, p = 0.03]. There were challenges with the integration of HIV and BU care in this cohort. CONCLUSION: The prevalence of HIV in the BU+ infected population was not significantly increased when compared to the prevalence of HIV in the general population. There was no clear relationship between BU lesion severity and HIV viral load or CD4 counts. Efforts should be made to encourage the integration of care of patients with BU-HIV coinfection.
format Online
Article
Text
id pubmed-8028811
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80288112021-04-09 Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana Amoako, Yaw Ampem Loglo, Aloysius Dzigbordi Frimpong, Michael Agbavor, Bernadette Abass, Mohammed Kabiru Amofa, George Ofori, Elizabeth Ampadu, Edwin Asiedu, Kingsley Stienstra, Ymkje Wansbrough-Jones, Mark van der Werf, Tjip Phillips, Richard Odame BMC Infect Dis Research Article BACKGROUND: Previous studies have reported that presence and severity of Buruli ulcer (BU) may reflect the underlying immunosuppression in HIV infected individuals by causing increased incidence of multiple, larger and ulcerated lesions. We report cases of BU-HIV coinfection and the accompanying programmatic challenges encountered in central Ghana. METHODS: Patients with PCR confirmed BU in central Ghana who were HIV positive were identified and their BU01 forms were retrieved and reviewed in further detail. A combined 16S rRNA reverse transcriptase / IS2404 qPCR assay was used to assess the Mycobacterium ulcerans load. The characteristics of coinfected patients (BU(+)HIV(+)) were compared with a group of matched controls. RESULTS: The prevalence of HIV in this BU cohort was 2.4% (compared to national HIV prevalence of 1.7%). Eight of 9 BU(+)HIV(+) patients had a single lesion and ulcers were the most common lesion type. The lesions presented were predominantly category II (5/9) followed by category I lesions. The median (IQR) time to healing was 14 (8–28) weeks in the BU(+)HIV(+) compared to 28 (12–33) weeks in the control BU(+)HIV(−) group (p = 0.360). Only one BU(+)HIV(+) developed a paradoxical reaction at week 16 but the lesion healed completely at week 20. The median bacterial load (16SrRNA) of BU(+)HIV(+) patients was 750 copies /ml (95% CI 0–398,000) versus 500 copies/ml (95% CI 0–126,855,500) in BU(+)HIV(−) group. Similarly, the median count using the IS2404 assay was 500 copies/ml (95% CI 0–500) for BU(+)HIV(+) patients versus 500 copies/ml (95% CI 500–31,000) for BU(+)HIV(−) patients. BU(+)HIV(−) patients mounted a significantly higher interferon-γ response compared to the BU(+)HIV(+) co-infected patients with respective median (range) responses of [1687(81.11–4399) pg/ml] versus [137.5(4.436–1406) pg/ml, p = 0.03]. There were challenges with the integration of HIV and BU care in this cohort. CONCLUSION: The prevalence of HIV in the BU+ infected population was not significantly increased when compared to the prevalence of HIV in the general population. There was no clear relationship between BU lesion severity and HIV viral load or CD4 counts. Efforts should be made to encourage the integration of care of patients with BU-HIV coinfection. BioMed Central 2021-04-08 /pmc/articles/PMC8028811/ /pubmed/33832460 http://dx.doi.org/10.1186/s12879-021-06009-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Amoako, Yaw Ampem
Loglo, Aloysius Dzigbordi
Frimpong, Michael
Agbavor, Bernadette
Abass, Mohammed Kabiru
Amofa, George
Ofori, Elizabeth
Ampadu, Edwin
Asiedu, Kingsley
Stienstra, Ymkje
Wansbrough-Jones, Mark
van der Werf, Tjip
Phillips, Richard Odame
Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
title Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
title_full Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
title_fullStr Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
title_full_unstemmed Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
title_short Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
title_sort co-infection of hiv in patients with buruli ulcer disease in central ghana
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028811/
https://www.ncbi.nlm.nih.gov/pubmed/33832460
http://dx.doi.org/10.1186/s12879-021-06009-7
work_keys_str_mv AT amoakoyawampem coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT logloaloysiusdzigbordi coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT frimpongmichael coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT agbavorbernadette coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT abassmohammedkabiru coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT amofageorge coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT oforielizabeth coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT ampaduedwin coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT asiedukingsley coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT stienstraymkje coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT wansbroughjonesmark coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT vanderwerftjip coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana
AT phillipsrichardodame coinfectionofhivinpatientswithburuliulcerdiseaseincentralghana